Opinion

Video

Identifying Nonadherence in Patients With Hyperlipidemia

Panelists discuss how clinical teams can identify and address nonadherence to statin and nonstatin therapies by leveraging electronic health record (EHR) systems for adherence monitoring and optimizing patient outcomes.

Nonadherence to Lipid-Lowering Therapies: Identification and Management Strategies

Key Approaches for Identifying Nonadherence

  • Direct assessment methods:
    • Medication possession ratio and proportion of days covered calculations
    • Pharmacy refill data monitoring
    • Prescription claims database analysis
    • Serum drug level measurements when available
  • Indirect assessment methods:
    • Structured patient interviews using validated questionnaires (e.g., Morisky Medication Adherence Scale)
    • Patient self-reporting with nonjudgmental questioning
    • Clinical response evaluation (monitoring lipid levels for expected reductions)

Effective Interventions for Improving Adherence

  • Simplification of regimens: Once-daily dosing, fixed-dose combinations, and polypills
  • Patient education: Personalized counseling about cardiovascular risk and medication benefits
  • Behavioral interventions: Reminder systems, medication organizers, and habit formation
  • Shared decision-making: Involving patients in treatment decisions and addressing concerns
  • Team-based care: Leveraging pharmacists, nurses, and care managers for adherence support
  • Cost-reduction strategies: Prescribing generics, assistance programs, and formulary optimization

Electronic Medical Record - Based Strategies for Adherence Monitoring

  • Implement automated alerts for missed refills or appointments
  • Create dashboards displaying medication adherence metrics
  • Design clinician-friendly adherence assessment tools within workflow
  • Integrate prescription claims data with clinical systems when possible
  • Develop standardized documentation templates for adherence discussions
  • Utilize patient portals for education and medication reminders
  • Configure clinical decision support tools to identify high-risk patients

Implementation Recommendations

  • Establish systematic screening for nonadherence during routine visits
  • Use multifaceted interventions tailored to specific adherence barriers
  • Apply quality improvement methodology to local adherence initiatives
  • Monitor program effectiveness with clearly defined metrics
  • Consider adherence monitoring as an essential component of lipid management
Related Videos
5 experts in this video
1 expert is featured in this series.
1 expert is featured in this series.
5 experts in this video
5 experts in this video
1 expert is featured in this series.
1 expert is featured in this video series.
5 experts in this video